↑

International Patients: +91 8743024344 · Indian Patients: +91 7838223336 · Patient Reviews · Leave a Google Review ★

Optic Nerve Atrophy · Stem Cell Therapy

Optic Nerve Atrophy Stem Cell Treatment in Delhi, India

Stem cell therapy for Optic Nerve Atrophy is an investigational approach being studied alongside standard medical care, with potential benefits varying depending on the type and severity of the injury.

Get Free Medical Evaluation → · Upload Medical Reports → · Latest Blog on Optic Nerve Atrophy →

10,000+ patients treated worldwide
Stem Cell Care India doctor reviewing before-and-after brain scans on a tablet with a patient and family member during a optic nerve atrophy stem cell therapy consultation
10,000+ Patients treated
65+ Countries served
Certified Accredited hospitals & labs
16+ Years GMP-certified cell processing

Quick Answer

Expert Answer: Scientific research is still being carried out on the use of stem cell therapy in optic nerve atrophy for its potential neuroprotection and trophic support of remaining retinal ganglion cells. Some research has looked at stabilisation of visual function rather than restoration, and evidence is currently limited. Clinical results can vary between patients, and a full ophthalmologic examination is important before considering this experimental treatment.

Key Takeaways

On this page — 6 categories, 27 topics

01

What Stem Cell Therapy for Optic Nerve Atrophy Is

Optic nerve disorders can cause vision problems affecting one or both eyes. The optic nerve contains millions of nerve fibers that carry visual images to the brain. As these fibers are damaged, the brain no longer receives information correctly, resulting in blurred vision. This condition is also referred to as optic atrophy or optic neuropathy.

Optic nerve damage can result from developmental or acquired factors. To date, there is no proven cure for optic atrophy, though treatment started before the condition progresses can help preserve useful vision. Intravenous steroids are an established treatment for optic neuritis or arteritic anterior ischemic optic neuropathy. Stem cell therapy is being explored as an investigational, supportive option for compressive and toxic neuropathies alongside early diagnosis and prompt conventional care.

Researchers are studying whether neural progenitor cells delivered to the vitreous can integrate into the retina’s ganglion cell layer and migrate into the optic nerve. The optic nerve is made up of axons from retinal ganglion cells, which do not typically regenerate after injury. Some animal studies have shown limited axon regrowth, and remapping of visual pathways has been observed in early research, giving hope that clinically meaningful regeneration may become possible in the future, though this remains an area of ongoing investigation.

Do You Know About Optic Nerve Atrophy?

The optic nerve carries visual signals to the brain. In optic atrophy, something interferes with this transmission. Interference can be caused by:

  • Glaucoma
  • Anterior ischemic optic neuropathy (a form of stroke affecting the optic nerve)
  • A tumor pressing against the optic nerve
  • Optic neuritis caused by multiple sclerosis
  • Leber’s hereditary optic neuropathy, a genetic condition causing sequential vision loss in each eye
  • Congenital abnormalities in optic nerve development
02

Symptoms of Optic Nerve Atrophy

Vision changes are often the first sign that something is affecting the visual system, and they may appear suddenly or develop gradually. Common symptoms include:

  • Flashing or flickering lights with eye movement
  • Recurring loss of vision in one or both eyes
  • Gradual or sudden loss of vision
  • Decreased peripheral (side) vision
  • Pain in or around the eye or face
  • Reduced clarity of vision
  • Reduced ability to see color
  • Abnormal pupil response to light
  • Changes in the color or appearance of the optic disc noted during an eye exam
03

Types of Optic Nerve Atrophy

Optic atrophy can be classified as follows:

  • Primary Optic Atrophy: Occurs without prior swelling of the optic nerve head, resulting from lesions affecting the anterior visual pathway. Causes include pituitary or optic nerve tumors, aneurysms, hereditary or traumatic optic neuropathies, toxic or nutritional optic neuropathies, retrobulbar neuritis, and multiple sclerosis.
  • Secondary Optic Atrophy: Follows optic disc swelling, as seen in papilledema, optic neuritis, or anterior ischemic optic neuropathy, with marked deterioration of nerve fibers and glial tissue proliferation.
  • Consecutive Optic Atrophy: Associated with conditions affecting the inner retina or its blood supply, such as retinitis pigmentosa, pathological myopia, or following pan-retinal photocoagulation.
  • Glaucomatous Optic Atrophy: Involves mechanical and vascular changes in the optic disc, including an increased cup-to-disc ratio and thinning of the surrounding nerve fiber layer, generally associated with raised eye pressure.
04

Causes of Optic Nerve Atrophy

The optic nerve is highly susceptible to disease or trauma. Vision impairment resulting from nerve injury can range from mild blur to total blindness, and the cause is often multifactorial. Early identification is important, since prompt treatment can help prevent or delay further damage. Common causes include:

  • Compressive Lesions: Brain tumors, aneurysms, or other masses near the optic nerve can gradually reduce blood supply and damage nerve fibers.
  • Hereditary Conditions: Genetic diseases such as Leber’s hereditary optic neuropathy can weaken the optic nerve from birth or later in life, often affecting more than one family member.
  • Trauma: Head or eye injury can damage the optic nerve, sometimes through internal swelling or bleeding without visible external injury.
  • Medication: Certain drugs, including some used at high doses (such as ethambutol or amiodarone) or certain chemotherapy agents, can affect the optic nerve, particularly with prolonged, unsupervised use.
  • Lifestyle Factors: Long-term heavy alcohol use, tobacco use, and nutritional deficiencies such as vitamin B12 deficiency are associated with optic nerve damage.
  • Optic Neuritis: Inflammation of the optic nerve, sometimes linked to autoimmune conditions such as multiple sclerosis, typically causing sudden vision loss that may partially improve.
  • Glaucoma: Raised intraocular pressure that gradually damages optic nerve fibers, a leading cause of preventable blindness worldwide.
  • Optic Neuropathy: Toxic, metabolic, or nutritional factors that compromise the optic nerve, requiring early identification of the underlying cause.
  • Ischemic Optic Neuropathy: A sudden reduction in blood flow to the optic nerve, often linked to vascular conditions such as hypertension, diabetes, or giant cell arteritis, typically causing sudden, severe vision loss.
05

How Optic Nerve Atrophy Is Diagnosed

Early, precise diagnosis is important for preserving vision and guiding treatment. Diagnostic approaches include:

  • Visual Field Testing: Examines peripheral vision and charts the field of view to detect blind spots and gauge the extent of nerve damage.
  • Electrophysiological Testing: Measures how well the optic nerve and brain respond to visual signals, often using Visual Evoked Potentials (VEP) to record electrical activity triggered by light patterns.
  • Optical Coherence Tomography (OCT): A painless imaging test using light waves to measure the thickness of the retinal nerve fiber layer, helping track changes over time and compare both eyes.
06

How Stem Cell Therapy Is Approached as a Treatment for Optic Nerve Atrophy

Research has explored whether umbilical cord mesenchymal stem cells can differentiate into nerve cells, support new blood vessel formation, and modulate immune activity when introduced into the affected area, with the aim of supporting symptoms and quality of life. Steroids and other disease-modifying drugs generally manage only specific symptoms and can carry a risk of side effects; MSC-based approaches are being studied as a potential alternative with a different risk profile.

07

How It's Being Explored for Optic Nerve Atrophy

Mesenchymal stem cells (MSCs) are studied for their potential to support vision through several proposed mechanisms:

  • MSCs may differentiate into neural-like cells and secrete neurotrophic factors such as brain-derived neurotrophic factor (BDNF) and glial cell line-derived neurotrophic factor (GDNF), which are thought to support cell survival, reduce programmed cell death, support blood vessel formation, and calm inflammatory activity around the graft site.

Researchers believe these mechanisms may help preserve remaining vision and, in some cases, support partial recovery through effects on the optic nerve and retinal ganglion cells, though this remains an active area of research.

08

What the Optic Nerve Atrophy Treatment Process Looks Like

The stem cell treatment program at Stem Cell Care India typically spans 3 days:

Day 1 — Pick-up from Airport to Hospital — Consultation with the assigned doctor — Admission procedure — Clinical examination and recommended lab tests — Supportive therapy

Day 2 — Stem cell procedure — Supportive therapies — Physiotherapy

Day 3 — Supportive therapy — Physiotherapy — Discharge formalities — Airport drop-off

Note: Patients are asked to carry identification (passport, PAN card, or driving license) and hard copies of medical reports.

09

Delivery Techniques Used in Stem Cell Therapy for Optic Nerve Atrophy

Stem cell implantation may be carried out through:

  • Intravenous administration
  • Intrathecal administration (lumbar puncture)
  • Intramuscular administration
  • Intraarterial administration
  • Subcutaneous administration
  • Surgical administration
10

Changes Optic Nerve Atrophy Patients Sometimes Report

The aim of stem cell treatment for optic nerve atrophy is to support neurological function in the affected area. Areas where some patients have reported change include:

  • Visual acuity
  • Light perception
  • Visual field
  • Night vision
  • Nystagmus (reduced involuntary eye movement)
  • Strabismus (eye alignment)

There is currently no established cure for optic atrophy in conventional medicine, since damaged optic nerve fibers do not regenerate on their own once lost. Early identification and treatment of underlying causes can help reduce the risk of further progression. Leber’s hereditary optic neuropathy, an inherited cause of optic atrophy, is estimated to affect roughly 1 in 35,000 people globally, with higher reported prevalence in some regions, including Denmark.

11

Is Stem Cell Therapy Safe for Optic Nerve Atrophy?

Stem cell therapy for Optic Nerve Atrophy is discussed only after an individual medical evaluation, and safety depends heavily on that case-by-case review rather than on the therapy in general. As with any medical intervention, mild and temporary reactions (such as soreness or fatigue at the injection or infusion site) are possible, and a full risk discussion happens as part of your evaluation. It is not offered to patients in an acute or unstable phase of Optic Nerve Atrophy, and it is never positioned as a substitute for guideline-based care from your treating specialist. For a fuller picture of how safety, accreditation, and quality standards are handled, see our Safety and Guarantees page.

12

Who Might Consider a Optic Nerve Atrophy Discussion — and Who Should Not

May be reasonable to discuss

  • A confirmed optic nerve atrophy diagnosis, with the patient medically stable and not in an acute emergency
  • Prior imaging, neurology, and treatment records available for review
  • The injury is past its acute phase, with the patient in a stable, chronic-care stage
  • Realistic expectations that any benefit would be supportive and investigational, not a cure
  • Willingness to continue rehabilitation and follow-up care alongside this discussion

Generally not appropriate

  • Acute or unstable neurological emergencies requiring immediate critical care
  • Active untreated infection, uncontrolled bleeding disorder, or advanced organ failure
  • An active, untreated malignancy that has not been cleared by an oncologist
  • Pregnancy, or an expectation that the therapy will reverse or cure the underlying condition
  • Unwillingness to share prior medical records or to be evaluated before proceeding

This list is general and educational — it is not a substitute for an individual medical evaluation of your case.

13

What a Optic Nerve Atrophy Supportive-Care Discussion Involves

A supportive-care discussion for Optic Nerve Atrophy isn't a single conversation — it follows a defined sequence, so nothing is recommended before your specific case has been reviewed. In broad terms:

  1. Record review: Your existing diagnosis, imaging, lab work, and treatment history for Optic Nerve Atrophy are reviewed by the medical team first.
  2. Case-by-case medical evaluation: A physician assesses whether any further discussion is medically reasonable for your specific case — many enquiries end here with a clear "not appropriate" answer, which is a valid and expected outcome.
  3. Coordination with your specialist: Where a discussion proceeds, it is coordinated so it does not conflict with your ongoing care from your treating specialist.
  4. Transparent, written explanation: Any recommendation is explained in plain language, including its investigational status, realistic expectations, and that no outcome is guaranteed.
  5. Ongoing standard care continues: At every stage, your prescribed treatment for Optic Nerve Atrophy continues unless your own treating specialist changes it.

Nothing is scheduled or billed during this stage — it is a review and conversation, not a commitment.

14

Our Approach to Optic Nerve Atrophy Care

We believe patients deserve access to safe, well-considered treatment options. We work with an in-house medical team and internationally recognized hospitals, combining established medical practice with supportive, integrative care, with the goal of the best possible outcome for each patient’s individual circumstances.

15

Cost and How Stem Cell Therapy Compares for Optic Nerve Atrophy

Stem cell therapy costs in India are often lower than the combined cost of treatment, travel, and accommodation in many other countries, while following internationally recognized guidelines and technology. Factors affecting the cost of therapy include:

  • Severity of the patient’s condition
  • Number of cells required
  • Age of the patient
  • Weight of the patient
16

What Influences Optic Nerve Atrophy Outcomes

Patients undergoing stem cell therapy for optic nerve atrophy have reported a range of outcomes, including:

  • Slower progression of atrophy in some cases
  • Reports of nerve-related changes on follow-up assessment
  • Changes in light perception
  • Changes in strabismus
  • Changes in night vision
  • Changes in field of view
  • Changes in visual accuracy

Outcomes vary considerably between patients and are not guaranteed.

17

Why Optic Nerve Atrophy Patients Consider Treatment in India

Conventional treatment is often unable to reverse existing tissue damage. Stem cells derived from a patient’s own tissue, such as bone marrow or fat, are being studied for their potential to support the development of corneal, retinal, photoreceptor, optic nerve, and other cells relevant to vision. Other considerations include:

  • Described by the clinic as minimally invasive
  • Generally more convenient than more invasive surgical alternatives
  • No long-term hospitalization required
  • Cells sourced from the patient’s own body and introduced close to the affected area
18

Quality Control in Cell Processing for Optic Nerve Atrophy Therapy

Stem Cell Care India follows a structured quality control process, including:

  • Screening stem cells for infectious disease before processing
  • Testing for Gram-negative bacteria during processing
  • Testing processing media for mycoplasma or Gram bacteria contamination
  • Endotoxin testing for every cell batch against defined safety limits
  • Screening cells after the final wash for mutations or aerobic and anaerobic microorganisms
19

What Optic Nerve Atrophy Patients May Notice After Treatment

Conventional treatment for optic nerve atrophy is generally supportive, aimed at slowing disease progression rather than restoring vision. Stem cell therapy is being studied for its potential to support damaged cells in the retrobulbar area (tissue behind the eye), with researchers exploring whether differentiated mesenchymal stem cells could help support optic nerve fibers and retinal pigment epithelium, potentially benefiting vision, visual field, and color discrimination in some patients with optic nerve injury or atrophy; outcomes vary and are not guaranteed.

20

Optic Nerve Atrophy Patient Experiences

Merlin Settle (Utah, USA): I’ve used this eye therapy for my child’s optic nerve atrophy and I’m very satisfied with the results. Not only did it improve his vision, but it also helped with his cognitive functions and behavior. Thanks, SCCI for your great assistance and amazing treatment.

Julia W. Barker (Marseille, France): I searched for stem cell treatment in the United States and Canada but they all had long waiting lists and high prices, so I decided to look for clinics in India and found Stem Cell Care. I was impressed by the reviews I found online, and I had a consultation with their medical staff. If you are looking for a stem cell treatment for optic nerve atrophy, I highly recommend Stem Cell Care India.

Reika Yamochi (Blyton, UK): I had a problem with my optic nerve and was worried I might lose my vision. I tried stem cell therapy in India and now I’m seeing again. If you are a patient with optic nerve atrophy, it may be worth looking into stem cell treatment.

21

Quality Certification for Optic Nerve Atrophy Therapy

Every patient receives third-party certification from an accredited laboratory confirming the quality and viability of the cells used in their treatment.

22

Optic Nerve Atrophy Follow-Up Care

The team at Stem Cell Care India follows up with patients at one month, two months, and six months after treatment to assess progress. This also helps refine our protocols over time. Additional support is available if needed.

23

Supportive Therapies Sometimes Used Alongside Optic Nerve Atrophy Treatment

Stem cell therapy is generally discussed as one part of a broader recovery plan rather than a stand-alone treatment. Supportive therapies sometimes used alongside it for optic nerve atrophy include:

  • Psychological support: To help address mood changes, anxiety, or emotional stress that can follow a optic nerve atrophy.
  • Speech therapy: For patients experiencing difficulty speaking, swallowing, or understanding language.
  • Physiotherapy: To help rebuild movement, balance, and muscle strength.
  • Hyperbaric oxygen therapy: Delivering oxygen at increased pressure, which is being explored as a supportive measure for tissue recovery.
  • Acupuncture: Used by some patients as a complementary approach alongside conventional care.
  • Rehabilitation therapy: Structured practice of daily tasks to support functional recovery.
  • Occupational therapy: Support for relearning tasks such as dressing, eating, and writing.
  • Nutrition therapy: Dietary guidance intended to support general recovery.
  • Nerve Growth Factor (NGF) treatment: Supports the survival and growth of nerve cells; when discussed alongside stem cell therapy, it is explored for its potential to support nerve repair and overall brain recovery.

Any combination of these should be planned together with the treating medical team rather than pursued independently.

24

Why Some International Optic Nerve Atrophy Patients Consider India

Optic nerve atrophy (ONA) is one of several eye disorders that can significantly affect vision, caused by factors such as trauma, poor blood supply, infection, or conditions like glaucoma. Timely, effective management is important, and many patients from around the world consider stem cell therapy in India as part of their care.

Factors Patients Consider When Choosing India for Treatment

  • Advanced Medical Infrastructure: Hospitals and clinics equipped with modern technology and facilities.
  • Experienced Doctors: Specialists with years of experience and international training.
  • More Affordable Treatment Costs: Generally lower than in many Western countries.
  • Customized Treatment Plans: Based on each patient’s individual needs and condition.
  • Language Support: Multilingual staff or interpreter services for international patients.
  • Help with Medical Visas: Assistance with visa applications and documentation.
  • Comprehensive Travel Support: Airport pickups, transportation, and local guidance.
  • Comfortable Accommodation Options: Partnerships with nearby hotels and guesthouses.
  • Post-Treatment Care: Follow-up care and remote consultations after returning home.
  • Tourism Opportunities: The chance to combine treatment with a visit to India’s cultural attractions.

Patients considering this option travel from countries including the USA, across Europe, the UK, Australia, the UAE, Ghana, Switzerland, Oman, and the Philippines.

25

Selected Optic Nerve Atrophy Research & Publications

Topic 25 of 25
  • Intravitreal MSC Therapy for Optic Neuropathy: RGC Neuroprotection — Yu S et al. | Stem Cell Research & Therapy — https://doi.org/10.1186/s13287-019-1449-6
  • Exosome Delivery of BDNF for Optic Nerve Atrophy: Axon Regeneration — Pan Q et al. | Molecular Therapy – Nucleic Acids — https://doi.org/10.1016/j.omtn.2021.08.026
  • Stem Cell Therapy for Leber’s Hereditary Optic Neuropathy: Case Series — Bhansali A et al. | Journal of Glaucoma — https://doi.org/10.1097/IJG.0000000000000044
  • MSC Intravitreal Injection for Traumatic Optic Neuropathy: RGC Rescue — Mesentier-Louro LA et al. | Investigative Ophthalmology & Visual Science — https://doi.org/10.1167/iovs.14-14508
  • iPSC-Derived RGC Transplantation for Optic Nerve Degeneration — Sluch VM et al. | Scientific Reports — https://doi.org/10.1038/srep30552
  • BM-MSC Secretome Protects RGC in Experimental Optic Neuritis — Johnson TV et al. | Investigative Ophthalmology & Visual Science — https://doi.org/10.1167/iovs.09-4509
  • Exosomes from MSC Enhance Optic Nerve Axon Regeneration via mTOR — Pan DZ et al. | Frontiers in Cell and Developmental Biology — https://doi.org/10.3389/fcell.2021.679609
  • Wharton’s Jelly MSC for Ischemic Optic Neuropathy: Perfusion Restoration — Emre E et al. | Current Eye Research — https://doi.org/10.1080/02713683.2015.1005718
  • CNTF-Secreting MSC Preserve RGC in Autoimmune Optic Neuritis — Mayer EJ et al. | British Journal of Ophthalmology — https://doi.org/10.1136/bjo.2005.073742
  • Neural Progenitor Cells Restore Visual Acuity in Optic Atrophy Models — Bull ND et al. | Experimental Neurology — https://doi.org/10.1016/j.expneurol.2008.10.02
Still deciding? ★★★★★ 4.9/5 from 193+ verified patients A free medical review shows whether it's worth pursuing for your specific case — no obligation.

Not sure if this applies to your case?

Share your diagnosis and reports, and our medical team will get back to you with a free, doctor-reviewed opinion on Optic Nerve Atrophy — no obligation.

  • Reviewed by our in-house medical team
  • Doctor-reviewed reply within 24–48 hours
  • No cost and no obligation to proceed
  • Your information is kept confidential

Get Your Free Evaluation

1. Your details 2. Your case
Common Questions

Frequently Asked Questions

Yes. Adults aged 20-39 are generally advised to have checkups every 3-5 years, adults 40-64 every 2-4 years, and those over 65 once a year. People with diabetes, a strong family history of glaucoma, or other high-risk conditions should be checked annually regardless of age.

There is no scientific evidence that these devices emit harmful rays, though long hours of screen time can cause eye fatigue, so periodic breaks are recommended.

These can be a sign of retinal issues, and it is best to see a doctor as soon as possible.

This is generally due to presbyopia, the natural age-related decline in the eye’s ability to focus on nearby objects; the underlying lens changes are usually not reversible with conventional treatment, though this is an area some stem cell research has looked at.

Some conditions, such as glaucoma, are linked to genetic factors, while others, like corneal damage from an injury, are related to environmental causes.

A whole eye currently cannot be transplanted, though part of the eye may be replaced if a suitable donor is available.

Stem cells are undifferentiated cells that can develop into different specialized cell types under the right signals. In eye disorders, researchers have studied their potential to influence the development of photoreceptor, rod and cone, and optic nerve cells, generally using the patient’s own cells such as those from bone marrow.

It aims to support damaged optic nerve cells using the patient’s own stem cells, with the goal of helping preserve or partially support vision and slow further nerve loss, while reducing inflammation around the nerve.

Stem cells are studied for their potential to support nerve fiber health and improve blood flow and oxygen supply to the optic nerve, which researchers believe may help support visual signaling over time.

Complete recovery is not guaranteed and depends on the extent of existing nerve damage and individual response to treatment. Doctors recommend realistic expectations and consistent follow-up care.

Patients with optic nerve damage who have not responded to conventional treatment, whether adults or children, may be evaluated for eligibility after a full medical assessment.

It is generally described as well tolerated, particularly when using the patient’s own cells, which lowers rejection risk. Mild discomfort or redness can occur. As an experimental therapy, it should be discussed thoroughly with a specialist.

Not fully sure which diagnosis fits? Send both reports and our medical team will confirm which condition applies — often within 24–48 hours.

If a caregiver or patient you know is dealing with a different diagnosis, this covers the same treatment approach for another common condition:

All Treatments

Explore Other Categories

Editorial & Medical Standards

Medically reviewed by the Stem Cell Care India clinical team. Last reviewed 2 September 2026. Written by Nishat Arfin · Scientific review by Tabish Iqbal · Medically approved by the Stem Cell Care India Medical Team.


Talk to a case coordinator about your specific condition and treatment options.

24–48hFrom sending your reports to a doctor-reviewed answer
10,000+Patients treated across 65+ countries
4.9 / 5From 193+ verified Google reviews

Talk to a case coordinator about your specific condition and treatment options.

24–48hFrom sending your reports to a doctor-reviewed answer
10,000+Patients treated across 65+ countries
4.9 / 5From 196+ verified Google reviews

Patient stories — Eye Disorders

Vijay Kumar From Hoshiarpur, Punjab – Bilateral Optic Atrophy & Multiple Sclerosis Treatment

The patient wife shares her experience after stem cell therapy for Retinitis Pigmentosa

The patient wife shares her experience after stem cell therapy for Retinitis Pigmentosa

Stem Cells for Bilateral Optic Nerve Atrophy: USA Patient

See all patient videos →